[New aspects of anti-inflammatory therapy of rheumatic diseases: preclinical validation and clinical trial of meloxicam].
Nasonov
E L
EL
Institute of Rheumatology, RAMN.
Tsvetkova
E S
ES
Balabanova
R M
RM
Denisov
L N
LN
Alekseeva
L I
LI
Nasonova
V A
VA
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D006801:Humans; D000077239:Meloxicam; D011451:Prostaglandin-Endoperoxide Synthases / Q000187:drug effects / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis; D012216:Rheumatic Diseases / Q000188:drug therapy* / Q000378:metabolism; D013843:Thiazines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D011453:Prostaglandins; D013843:Thiazines; D013844:Thiazoles; D011451:Prostaglandin-Endoperoxide Synthases; D000077239:Meloxicam